Assessing circulating proteins HO-1, CypA, and IRE1 with combined neuroimaging to elucidate the mechanisms of neuronal damage in AD may help validate the continued use of these proteins in AD research. This evidence concerns the gene HMOX1 and Alzheimer disease.